Hippocampal Metastasis Rate Based on Non-Small Lung Cancer TNM Stage and Molecular Markers
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, Sung Jun | - |
dc.contributor.author | Kwon, Hyeokjin | - |
dc.contributor.author | Kim, Jun Won | - |
dc.contributor.author | Park, Goeun | - |
dc.contributor.author | Park, Mina | - |
dc.contributor.author | Joo, Bio | - |
dc.contributor.author | Suh, Sang Hyun | - |
dc.contributor.author | Chang, Yoon Soo | - |
dc.contributor.author | Lee, Jong-Min | - |
dc.date.accessioned | 2022-07-06T01:51:39Z | - |
dc.date.available | 2022-07-06T01:51:39Z | - |
dc.date.created | 2022-06-29 | - |
dc.date.issued | 2022-05 | - |
dc.identifier.issn | 2234-943X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/138377 | - |
dc.description.abstract | Hippocampal-avoidance whole-brain radiation therapy (HA-WBRT) is justified because of low hippocampal brain metastases (BM) rate and its prevention of cognitive decline. However, we hypothesize that the risk of developing BM in the hippocampal-avoidance region (HAR) may differ depending on the lung-cancer stage and molecular status. We retrospectively reviewed 123 patients with non-small cell lung cancer (NSCLC) at the initial diagnosis of BM. The number of BMs within the HAR (5 mm expansion) was counted. The cohort was divided into patients with and without BMs in the HAR, and their clinical variables, TNM stage, and epidermal growth factor receptor (EGFR) status were compared. The most influential variable predicting BMs in the HAR was determined using multi-variable logistic regression, classification and regression tree (CART) analyses, and gradient boosting method (GBM). The feasibility of HAR expansion was tested using generalized estimating equation marginal model. Patients with BMs in the HAR were more frequently non-smokers, and more likely to have extra-cranial metastases and EGFR mutations (p<0.05). Multi-variable analysis revealed that extra-cranial metastases were independently associated with the presence of BM in the HAR (odds ratio=8.75, p=0.04). CART analysis and GBM revealed that the existence of extra-cranial metastasis was the most influential variable predicting BM occurrence in the HAR (variable importance: 23% and relative influence: 37.38). The estmated BM incidence of patients without extra-cranial metastases in th extended HAR (7.5-mm and 10-mm expansion) did not differ significantly from that in the conventional HAR. In conclusion, NSCLC patients with extra-cranial metastases were more likely to have BMs in the HAR than those without extra-cranial metastases. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | FRONTIERS MEDIA SA | - |
dc.title | Hippocampal Metastasis Rate Based on Non-Small Lung Cancer TNM Stage and Molecular Markers | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Jong-Min | - |
dc.identifier.doi | 10.3389/fonc.2022.781818 | - |
dc.identifier.wosid | 000799995600001 | - |
dc.identifier.bibliographicCitation | FRONTIERS IN ONCOLOGY, v.12, pp.1 - 10 | - |
dc.relation.isPartOf | FRONTIERS IN ONCOLOGY | - |
dc.citation.title | FRONTIERS IN ONCOLOGY | - |
dc.citation.volume | 12 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 10 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | WHOLE-BRAIN RADIOTHERAPY | - |
dc.subject.keywordPlus | ALK REARRANGEMENT | - |
dc.subject.keywordPlus | LIMBIC CIRCUIT | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | EGFR | - |
dc.subject.keywordPlus | RADIOSURGERY | - |
dc.subject.keywordPlus | AVOIDANCE | - |
dc.subject.keywordPlus | MUTATIONS | - |
dc.subject.keywordPlus | PROGNOSIS | - |
dc.subject.keywordAuthor | Non-small cell lung cancer | - |
dc.subject.keywordAuthor | Brain metastasis | - |
dc.subject.keywordAuthor | Hippocampal-avoidance whole-brain radiation therapy | - |
dc.subject.keywordAuthor | Epidermal growth factor receptor | - |
dc.subject.keywordAuthor | lung-cancer stage | - |
dc.identifier.url | https://www.frontiersin.org/articles/10.3389/fonc.2022.781818/full | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.